The trophon®3 device and trophon2 Plus are now available in the U.S. and Canada. INDIANAPOLIS, Aug. 14, 2025 /PRNewswire/ -- Nanosonics, Inc., a global leader in infection prevention solutions, is ...
Johnson & Johnson acquires Halda Therapeutics for $3 billion to strengthen its oncology portfolio, focusing on prostate cancer therapies. The acquisition includes HLD-0915, a clinical-stage therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback